Pharma News

New clinical trials to evaluate long-acting, injectable antiretroviral drugs to prevent HIV

  • Posted on: 25 February 2015
  • By: PharmaTutor News

Two new clinical trials are examining the safety and acceptability of antiretroviral medicines administered via injection as a means of protecting against HIV infection. The studies are being funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), and conducted by the NIAID-funded HIV Prevention Trials Network (HPTN).

Poor Sleep may lead to Alcohol, Drug problems in Teens

  • Posted on: 23 February 2015
  • By: PharmaTutor News

Adolescents who get poor or insufficient sleep may be at higher risk of developing alcohol and drug problems, scientists say. Researchers have found that sleep difficulties and hours of sleep can predict a number of specific problems, including binge drinking, driving under the influence of alcohol, and risky sexual behaviour.

Google to Halt Sale of Google Glass

  • Posted on: 21 February 2015
  • By: admin

Google is set to discontinue the sale of its smart eyewear Google Glass, but the tech giant plans to release new, consumer-friendly versions of the device in the future. Google has announced that it will no longer sell its experimental first version of Glass which went on sale in the UK last year priced at 1,000 pounds.

Hospira launches first biosimilar monoclonal antibody (mAb) Inflectra™ (infliximab) in major European markets

  • Posted on: 17 February 2015
  • By: PharmaTutor News

-- Major European markets can finally benefit from the availability of Inflectra following the patent expiry of reference product Remicade® (infliximab)
-- Inflectra provides an alternative, potentially more affordable treatment option for people suffering from severe, debilitating diseases such as rheumatoid arthritis and inflammatory bowel disease while maintaining comparable quality, efficacy and safety to the reference product

NPPA notify pharma companies to maintain adequate stock of swine flu drugs

  • Posted on: 17 February 2015
  • By: PharmaTutor News

Due to increasing cases of swine flu in India, it was came to know that swine flu drugs are running short in stock. Therefore, National Pharmaceutical Pricing Authority (NPPA) asks pharma companies to maintain adequate amount of swine flu drug in the country to ensure a smooth supply of medicines.

Stem Cells that Regenerate Bones and Cartilage Identified

  • Posted on: 17 February 2015
  • By: PharmaTutor News

Researchers, including one of Indian-origin, have identified stem cells capable of regenerating both bone and cartilage in mice. Researchers at Columbia University Medical Center (CUMC) discovered the cells, called osteochondroreticular (OCR) stem cells, in bone marrow of mice by tracking a protein expressed by the cells.